Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 217

    1.

    Crushed clopidogrel administered via nasogastric tube has faster and greater absorption than oral whole tablets.

    Zafar MU, Farkouh ME, Fuster V, Chesebro JH.

    J Interv Cardiol. 2009 Aug;22(4):385-9. Epub 2009 May 28.PMID: 19496900 [PubMed - in process]Related articles

    2.

    A comparison of the blood pressure changes of lumiracoxib with those of ibuprofen and naproxen.

    Farkouh ME, Verheugt FW, Ruland S, Kirshner H, Jeger R, Gitton X, Krammer G, Stricker K, Sallstig P, Mellein B, Matchaba P, Chesebro JH.

    J Clin Hypertens (Greenwich). 2008 Aug;10(8):592-602.PMID: 18772641 [PubMed - indexed for MEDLINE]Related articles

    3.

    Diabetic atherothrombosis: helpful adjunctive therapy.

    Chesebro JH.

    Eur Heart J. 2008 Sep;29(18):2191-2. Epub 2008 Aug 8. No abstract available. PMID: 18689803 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Does bivalirudin reduce the incidence of bleeding in patients with acute coronary syndromes undergoing PCI?

    Chesebro JH.

    Nat Clin Pract Cardiovasc Med. 2007 Sep;4(9):476-7. Epub 2007 Jul 17. No abstract available. PMID: 17637722 [PubMed]Related articles

    5.

    Cardiovascular outcomes in high risk patients with osteoarthritis treated with ibuprofen, naproxen or lumiracoxib.

    Farkouh ME, Greenberg JD, Jeger RV, Ramanathan K, Verheugt FW, Chesebro JH, Kirshner H, Hochman JS, Lay CL, Ruland S, Mellein B, Matchaba PT, Fuster V, Abramson SB.

    Ann Rheum Dis. 2007 Jun;66(6):764-70. Epub 2007 Apr 5.PMID: 17412741 [PubMed - indexed for MEDLINE]Related articles

    6.

    Potent arterial antithrombotic effect of direct factor-Xa inhibition with ZK-807834 administered to coronary artery disease patients.

    Zafar MU, Farkouh ME, Osende J, Shimbo D, Palencia S, Crook J, Leadley R, Fuster V, Chesebro JH.

    Thromb Haemost. 2007 Mar;97(3):487-92.PMID: 17334518 [PubMed - indexed for MEDLINE]Related articles

    7.

    Stress testing and troponin in unstable coronary syndromes: the status trial-clinical outcomes and resource use.

    Estrada JN, Rolandi F, Bansilal S, Averbuj P, Natale E, Zafar MU, Santra M, Barbiere J, Chesebro JH, Farkouh ME.

    Am Heart Hosp J. 2006 Fall;4(4):252-8; quiz 259-60.PMID: 17086005 [PubMed - indexed for MEDLINE]Related articles

    8.

    Direct thrombin inhibitors are not equally effective in vivo against arterial thrombosis: in vivo evaluation of DuP714 and argatroban in a porcine angioplasty model and comparison to r-hirudin.

    McBane RD 2nd, Hassinger NL, Mruk JS, Grill DE, Chesebro JH.

    Thromb Res. 2005;116(6):525-32. Epub 2005 Mar 19.PMID: 16181988 [PubMed - indexed for MEDLINE]Related articles

    9.

    Inhibition and reversal of platelet-rich arterial thrombus in vivo: direct vs. indirect factor Xa inhibition.

    Karnicki K, McBane RD 2nd, Miller RS, Leadley RJ Jr, Morser J, Owen WG, Chesebro JH.

    J Thromb Haemost. 2004 Dec;2(12):2162-9.PMID: 15613022 [PubMed - indexed for MEDLINE]Related articles

    10.

    The incremental value of troponin-I testing in patients with intermediate risk unstable angina.

    Appelbaum E, Zafar MU, Glick HC, Stec S, Southern W, Sarkozi L, Wallenstein S, Chesebro JH, Farkouh ME.

    Clin Cardiol. 2004 Nov;27(11):646-51.PMID: 15562936 [PubMed - indexed for MEDLINE]Related articles

    11.

    Acute coronary syndromes: pathogenesis, acute diagnosis with risk stratification, and treatment.

    Chesebro JH.

    Am Heart Hosp J. 2004 Fall;2(4 Suppl 1):21-30. Review.PMID: 15539972 [PubMed - indexed for MEDLINE]Related articles

    12.

    The impact of vitamin K-dependent factor depletion by warfarin on platelet-rich thrombosis after deep arterial injury.

    McBane RD 2nd, Hassinger NL, Grill DE, Chesebro JH.

    J Thromb Haemost. 2004 Oct;2(10):1834-41.PMID: 15456496 [PubMed - indexed for MEDLINE]Related articles

    13.

    Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), cardiovascular outcomes: randomised controlled trial.

    Farkouh ME, Kirshner H, Harrington RA, Ruland S, Verheugt FW, Schnitzer TJ, Burmester GR, Mysler E, Hochberg MC, Doherty M, Ehrsam E, Gitton X, Krammer G, Mellein B, Gimona A, Matchaba P, Hawkey CJ, Chesebro JH; TARGET Study Group.

    Lancet. 2004 Aug 21-27;364(9435):675-84.PMID: 15325832 [PubMed - indexed for MEDLINE]Related articles

    14.

    Direct thrombin inhibitor therapy in the cardiovascular patient.

    Chesebro JH.

    Am J Health Syst Pharm. 2003 Oct 15;60 Suppl 5:S19-26.PMID: 14593979 [PubMed - indexed for MEDLINE]Related articles

    15.

    From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part II.

    Naghavi M, Libby P, Falk E, Casscells SW, Litovsky S, Rumberger J, Badimon JJ, Stefanadis C, Moreno P, Pasterkamp G, Fayad Z, Stone PH, Waxman S, Raggi P, Madjid M, Zarrabi A, Burke A, Yuan C, Fitzgerald PJ, Siscovick DS, de Korte CL, Aikawa M, Airaksinen KE, Assmann G, Becker CR, Chesebro JH, Farb A, Galis ZS, Jackson C, Jang IK, Koenig W, Lodder RA, March K, Demirovic J, Navab M, Priori SG, Rekhter MD, Bahr R, Grundy SM, Mehran R, Colombo A, Boerwinkle E, Ballantyne C, Insull W Jr, Schwartz RS, Vogel R, Serruys PW, Hansson GK, Faxon DP, Kaul S, Drexler H, Greenland P, Muller JE, Virmani R, Ridker PM, Zipes DP, Shah PK, Willerson JT.

    Circulation. 2003 Oct 14;108(15):1772-8. Review.PMID: 14557340 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I.

    Naghavi M, Libby P, Falk E, Casscells SW, Litovsky S, Rumberger J, Badimon JJ, Stefanadis C, Moreno P, Pasterkamp G, Fayad Z, Stone PH, Waxman S, Raggi P, Madjid M, Zarrabi A, Burke A, Yuan C, Fitzgerald PJ, Siscovick DS, de Korte CL, Aikawa M, Juhani Airaksinen KE, Assmann G, Becker CR, Chesebro JH, Farb A, Galis ZS, Jackson C, Jang IK, Koenig W, Lodder RA, March K, Demirovic J, Navab M, Priori SG, Rekhter MD, Bahr R, Grundy SM, Mehran R, Colombo A, Boerwinkle E, Ballantyne C, Insull W Jr, Schwartz RS, Vogel R, Serruys PW, Hansson GK, Faxon DP, Kaul S, Drexler H, Greenland P, Muller JE, Virmani R, Ridker PM, Zipes DP, Shah PK, Willerson JT.

    Circulation. 2003 Oct 7;108(14):1664-72. Review.PMID: 14530185 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Aspirin and mortality from coronary bypass surgery.

    Chesebro JH, Fuster V, Pugo FJ.

    N Engl J Med. 2003 Mar 13;348(11):1057-9; author reply 1057-9. No abstract available. PMID: 12637618 [PubMed - indexed for MEDLINE]Related articles

    18.

    Association between troponin I levels and mortality in stable hemodialysis patients.

    Farkouh ME, Robbins MJ, Urooj Zafar M, Shimbo D, Davidson KW, Puttappa R, Winston J, Halperin JL, Epstein EM, Patel M, Talor Z, Chesebro JH.

    Am J Med. 2003 Feb 15;114(3):224-6. No abstract available. PMID: 12637137 [PubMed - indexed for MEDLINE]Related articles

    19.

    Early coronary angiography improves long-term survival in unstable angina.

    Mathew V, Farkouh ME, Gersh BJ, Rihal CS, Reeder GS, Grill DE, Urban LH, Kopecky SL, Chesebro JH, Holmes DR Jr.

    Am Heart J. 2001 Nov;142(5):768-74.PMID: 11685161 [PubMed - indexed for MEDLINE]Related articles

    20.

    Evaluating the place of low-molecular-weight heparin in the management of acute coronary syndromes. A panel discussion with audience participation.

    Chesebro JH, Verheugt FW, Kontny F, Fry ET, Wallentin L, Camm AJ, Bechtold H.

    Clin Cardiol. 2001 Mar;24(3 Suppl):I20-2. No abstract available. PMID: 11286311 [PubMed - indexed for MEDLINE]Related articles

    21.

    Acute coronary care and beyond: the expanding role of low-molecular-weight heparin.

    Verheugt FW, Chesebro JH.

    Clin Cardiol. 2001 Mar;24(3 Suppl):I1-2. No abstract available. PMID: 11286308 [PubMed - indexed for MEDLINE]Related articles

    22.

    Thrombus formation on atherosclerotic plaques: pathogenesis and clinical consequences.

    Rauch U, Osende JI, Fuster V, Badimon JJ, Fayad Z, Chesebro JH.

    Ann Intern Med. 2001 Feb 6;134(3):224-38. Review.PMID: 11177336 [PubMed - indexed for MEDLINE]Related articlesFree article

    23.

    Chronic endothelial dysfunction after oversized coronary balloon angioplasty in pigs: a 12-week follow-up of coronary vasoreactivity in vivo and in vitro.

    Fonseca FA, Izar MC, Fuster V, Gallo R, Padurean A, Fallon JT, Schachter EN, Chesebro JH, Badimon JJ.

    Atherosclerosis. 2001 Jan;154(1):61-9.PMID: 11137083 [PubMed - indexed for MEDLINE]Related articles

    24.

    Inhibition of tissue factor reduces thrombus formation and intimal hyperplasia after porcine coronary angioplasty.

    Roqué M, Reis ED, Fuster V, Padurean A, Fallon JT, Taubman MB, Chesebro JH, Badimon JJ.

    J Am Coll Cardiol. 2000 Dec;36(7):2303-10.PMID: 11127477 [PubMed - indexed for MEDLINE]Related articles

    25.

    Statins and cardiovascular diseases: the multiple effects of lipid-lowering therapy by statins.

    Rauch U, Osende JI, Chesebro JH, Fuster V, Vorchheimer DA, Harris K, Harris P, Sandler DA, Fallon JT, Jayaraman S, Badimon JJ.

    Atherosclerosis. 2000 Nov;153(1):181-9.PMID: 11058714 [PubMed - indexed for MEDLINE]Related articles

    26.

    Acute antithrombotic effect of a front-loaded regimen of clopidogrel in patients with atherosclerosis on aspirin.

    Helft G, Osende JI, Worthley SG, Zaman AG, Rodriguez OJ, Lev EI, Farkouh ME, Fuster V, Badimon JJ, Chesebro JH.

    Arterioscler Thromb Vasc Biol. 2000 Oct;20(10):2316-21.PMID: 11031221 [PubMed - indexed for MEDLINE]Related articlesFree article

    27.

    Increased thrombus formation relates to ambient blood glucose and leukocyte count in diabetes mellitus type 2.

    Rauch U, Crandall J, Osende JI, Fallon JT, Chesebro JH, Fuster V, Badimon JJ.

    Am J Cardiol. 2000 Jul 15;86(2):246-9. No abstract available. PMID: 10913498 [PubMed - indexed for MEDLINE]Related articles

    28.

    Comparative study of antithrombotic effect of a low molecular weight heparin and unfractionated heparin in an ex vivo model of deep arterial injury.

    Roqué M, Rauch U, Reis ED, Chesebro JH, Fuster V, Badimon JJ.

    Thromb Res. 2000 Jun 15;98(6):499-505.PMID: 10899349 [PubMed - indexed for MEDLINE]Related articles

    29.

    In vivo magnetic resonance evaluation of atherosclerotic plaques in the human thoracic aorta: a comparison with transesophageal echocardiography.

    Fayad ZA, Nahar T, Fallon JT, Goldman M, Aguinaldo JG, Badimon JJ, Shinnar M, Chesebro JH, Fuster V.

    Circulation. 2000 May 30;101(21):2503-9.PMID: 10831525 [PubMed - indexed for MEDLINE]Related articlesFree article

    30.

    Antithrombotic effects of abciximab.

    Hayes R, Chesebro JH, Fuster V, Dangas G, Fallon JT, Sharma SK, Coller BS, Badimon L, Marmur JD, Badimon JJ.

    Am J Cardiol. 2000 May 15;85(10):1167-72.PMID: 10801995 [PubMed - indexed for MEDLINE]Related articles

    31.

    Prevalence of autoantibodies against contractile proteins in coronary artery disease and their clinical implications.

    Dangas G, Konstadoulakis MM, Epstein SE, Stefanadis CI, Kymionis GD, Toutouza MG, Liakos C, Sadaniantz A, Cohen AM, Chesebro JH, Toutouzas PK.

    Am J Cardiol. 2000 Apr 1;85(7):870-2, A6, A9.PMID: 10758929 [PubMed - indexed for MEDLINE]Related articles

    32.

    In vivo dynamic real-time monitoring and quantification of platelet-thrombus formation: use of a local isotope detector.

    Zaman AG, Osende JI, Chesebro JH, Fuster V, Padurean A, Gallo R, Worthley SG, Helft G, Rodriguez OX, Fallon JT, Badimon JJ.

    Arterioscler Thromb Vasc Biol. 2000 Mar;20(3):860-5.PMID: 10712414 [PubMed - indexed for MEDLINE]Related articlesFree article

    33.

    Introduction: Expanding the horizons in unstable coronary artery disease.

    Chesebro JH, Verheugt FW.

    Clin Cardiol. 2000 Jan;23 Suppl 1:I1-3. No abstract available. PMID: 10680036 [PubMed - indexed for MEDLINE]Related articles

    34.

    Flavone-8-acetic acid (Flavonoid) profoundly reduces platelet-dependent thrombosis and vasoconstriction after deep arterial injury In vivo.

    Mruk JS, Webster MW, Heras M, Reid JM, Grill DE, Chesebro JH.

    Circulation. 2000 Jan 25;101(3):324-8.PMID: 10645930 [PubMed - indexed for MEDLINE]Related articlesFree article

    35.

    Treatment of unstable angina: role of antithrombotic therapy.

    Gallo R, Chesebro JH, Badimon JJ.

    Thromb Res. 1999 Aug 1;95(3):V15-31. No abstract available. PMID: 10490065 [PubMed - indexed for MEDLINE]Related articles

    36.

    Antiplatelet therapy in the prevention of ischemic vascular events: literature review and evidence-based guidelines for drug selection.

    Zusman RM, Chesebro JH, Comerota A, Hartmann JR, Massin EK, Raps E, Wolf PA.

    Clin Cardiol. 1999 Sep;22(9):559-73. Review.PMID: 10486695 [PubMed - indexed for MEDLINE]Related articles

    37.

    Management strategies in unstable coronary artery disease--current problems and future directions. The UCAD Council.

    Verheugt FW, Becker RC, Bertrand ME, Bode C, Chesebro JH, Cleland JG, Conti R, Hillis WS, Klein W, Maseri A, Turpie AG, Wallentin L, Waters DD.

    Clin Cardiol. 1999 Sep;22(9):551-3.PMID: 10486693 [PubMed - indexed for MEDLINE]Related articles

    38.

    Lone atrial fibrillation in elderly persons: a marker for cardiovascular risk.

    Kopecky SL, Gersh BJ, McGoon MD, Chu CP, Ilstrup DM, Chesebro JH, Whisnant JP.

    Arch Intern Med. 1999 May 24;159(10):1118-22.PMID: 10335690 [PubMed - indexed for MEDLINE]Related articlesFree article

    39.

    Local inhibition of tissue factor reduces the thrombogenicity of disrupted human atherosclerotic plaques: effects of tissue factor pathway inhibitor on plaque thrombogenicity under flow conditions.

    Badimon JJ, Lettino M, Toschi V, Fuster V, Berrozpe M, Chesebro JH, Badimon L.

    Circulation. 1999 Apr 13;99(14):1780-7.PMID: 10199872 [PubMed - indexed for MEDLINE]Related articlesFree article

    40.

    Atherothrombosis: mechanisms and clinical therapeutic approaches.

    Fuster V, Badimon JJ, Chesebro JH.

    Vasc Med. 1998;3(3):231-9. Review.PMID: 9892516 [PubMed - indexed for MEDLINE]Related articles

    41.

    Different response to balloon angioplasty of carotid and coronary arteries: effects on acute platelet deposition and intimal thickening.

    Badimon JJ, Ortiz AF, Meyer B, Mailhac A, Fallon JT, Falk E, Badimon L, Chesebro JH, Fuster V.

    Atherosclerosis. 1998 Oct;140(2):307-14.PMID: 9862273 [PubMed - indexed for MEDLINE]Related articles

    42.

    Hirudin reduces tissue factor expression in neointima after balloon injury in rabbit femoral and porcine coronary arteries.

    Gertz SD, Fallon JT, Gallo R, Taubman MB, Banai S, Barry WL, Gimple LW, Nemerson Y, Thiruvikraman S, Naidu SS, Chesebro JH, Fuster V, Sarembock IJ, Badimon JJ.

    Circulation. 1998 Aug 11;98(6):580-7.PMID: 9714116 [PubMed - indexed for MEDLINE]Related articlesFree article

    43.

    Platelet glycoprotein IIb/IIIa receptor blockade in unstable coronary disease.

    Chesebro JH, Badimon JJ.

    N Engl J Med. 1998 May 21;338(21):1539-41. No abstract available. PMID: 9593795 [PubMed - indexed for MEDLINE]Related articles

    44.

    Dissolution of mural thrombus by specific thrombin inhibition with r-hirudin: comparison with heparin and aspirin.

    Meyer BJ, Badimon JJ, Chesebro JH, Fallon JT, Fuster V, Badimon L.

    Circulation. 1998 Feb 24;97(7):681-5.PMID: 9495304 [PubMed - indexed for MEDLINE]Related articlesFree article

    45.

    Prolonged thrombin inhibition reduces restenosis after balloon angioplasty in porcine coronary arteries.

    Gallo R, Padurean A, Toschi V, Bichler J, Fallon JT, Chesebro JH, Fuster V, Badimon JJ.

    Circulation. 1998 Feb 17;97(6):581-8.PMID: 9494029 [PubMed - indexed for MEDLINE]Related articlesFree article

    46.

    Tissue prothrombin. Universal distribution in smooth muscle.

    McBane RD 2nd, Miller RS, Hassinger NL, Chesebro JH, Nemerson Y, Owen WG.

    Arterioscler Thromb Vasc Biol. 1997 Nov;17(11):2430-6.PMID: 9409212 [PubMed - indexed for MEDLINE]Related articlesFree article

    47.

    Variability in anticoagulation control predicts thromboembolism after mechanical cardiac valve replacement: a 23-year population-based study.

    Huber KC, Gersh BJ, Bailey KR, Schaff HV, Hodge DO, Cha RH, Chesebro JH.

    Mayo Clin Proc. 1997 Dec;72(12):1103-10.PMID: 9413288 [PubMed - indexed for MEDLINE]Related articles

    48.

    Treatment of arterial thrombosis with low molecular weight heparins.

    Chesebro JH.

    Semin Hematol. 1997 Oct;34(4 Suppl 4):26-34. Review. No abstract available. PMID: 9399407 [PubMed - indexed for MEDLINE]Related articles

    49.

    Guidelines for management of left-sided prosthetic valve thrombosis: a role for thrombolytic therapy. Consensus Conference on Prosthetic Valve Thrombosis.

    Lengyel M, Fuster V, Keltai M, Roudaut R, Schulte HD, Seward JB, Chesebro JH, Turpie AG.

    J Am Coll Cardiol. 1997 Nov 15;30(6):1521-6. Review.PMID: 9362411 [PubMed - indexed for MEDLINE]Related articles

    50.

    Direct thrombin inhibition superior to heparin during and after thrombolysis: dose, duration, and drug.

    Chesebro JH.

    Circulation. 1997 Oct 7;96(7):2118-20. No abstract available. PMID: 9337177 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data

    Search details

    » See more...